These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1320238)

  • 41. Use of erythropoietin in Jehovah's Witness patients.
    Jim RT
    Hawaii Med J; 1990 Jun; 49(6):209. PubMed ID: 2397990
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hemopoietins in acute renal insufficiency caused by blood transfusion].
    Kakhetelidze MG; Komarov LS
    Probl Gematol Pereliv Krovi; 1967 Mar; 12(3):23-9. PubMed ID: 5619482
    [No Abstract]   [Full Text] [Related]  

  • 44. Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Peterlongo F; Castaigne JP; Zingraff J; Delons S
    Adv Nephrol Necker Hosp; 1989; 18():187-206. PubMed ID: 2493715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anaemia in children following cardiac transplantation: treatment with low dose human recombinant erythropoietin.
    Blackburn ME; Kendall RG; Gibbs JL; Dickinson DF; Parsons JM; Norfolk DR
    Int J Cardiol; 1992 Sep; 36(3):263-6. PubMed ID: 1428259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acute renal failure due to hemolytic transfusion incident following cesarean section].
    Houda W; Hofmann P
    Z Urol Nephrol; 1977 Aug; 70(8):585-8. PubMed ID: 919804
    [No Abstract]   [Full Text] [Related]  

  • 47. [Conservative treatment of infection and tumor anemia].
    Kubanek B
    Dtsch Med Wochenschr; 1979 Feb; 104(7):238-40. PubMed ID: 761512
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of erythropoietin in the management of anaemia in patients with pyroglutamic aciduria].
    Couce ML; Moure J; Pérez-Muñuzuri A; Aldamiz-Echevarría L; Fraga JM
    An Pediatr (Barc); 2011 Mar; 74(3):203-4. PubMed ID: 21342801
    [No Abstract]   [Full Text] [Related]  

  • 49. [Correction of anemia with human recombinant erythropoietin in a pregnant woman with renal failure].
    Marichal JF; Masson M
    Rev Med Interne; 1994 Feb; 15(2):149-50. PubMed ID: 8059125
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical applications of erythropoietin: Impact on blood transfusion].
    Sans T; Joven J
    Med Clin (Barc); 2002 Jul; 119(6):214-6. PubMed ID: 12200009
    [No Abstract]   [Full Text] [Related]  

  • 51. Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes.
    Johnson DW
    Evid Based Med; 2016 Oct; 21(5):178. PubMed ID: 27519812
    [No Abstract]   [Full Text] [Related]  

  • 52. Erythropoietin for patient refusing blood transfusion.
    Davis HP
    Lancet; 1990 Aug; 336(8711):384-5. PubMed ID: 1975371
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term treatment of the anaemia in Type 1 diabetes mellitus with erythropoietin.
    Winkler AS; Watkins PJ
    Diabet Med; 2000 Mar; 17(3):250-1. PubMed ID: 10784235
    [No Abstract]   [Full Text] [Related]  

  • 54. Erythropoietin in the treatment of anaemia in a nephropathic pregnant woman. Case report.
    D'Anna R; Scilipoti A
    Clin Exp Obstet Gynecol; 1996; 23(4):252-4. PubMed ID: 9001789
    [No Abstract]   [Full Text] [Related]  

  • 55. [Surveillance and side-effects of transfusions].
    Rezaei Kalantari H
    Rev Med Liege; 2002 Jun; 57(6):385-8. PubMed ID: 12180032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Protein-forming and excretory function of the liver in blood transfusion complications].
    Rzhanovich AP; Skachilova NN; Vinogradova IL
    Klin Med (Mosk); 1975 Mar; 53(3):105-9. PubMed ID: 1117665
    [No Abstract]   [Full Text] [Related]  

  • 57. [Is erythropoietin an adjuvant in hemotherapy?].
    Michaelis G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):661-4. PubMed ID: 9825052
    [No Abstract]   [Full Text] [Related]  

  • 58. [Posttransfusion renal insufficiency].
    Kiprenskiĭ IuV
    Feldsher Akush; 1978 May; 43(5):32-4. PubMed ID: 248330
    [No Abstract]   [Full Text] [Related]  

  • 59. More on transfusion and adverse outcome: it's time to change.
    Spahn DR; Shander A; Hofmann A; Berman MF
    Anesthesiology; 2011 Feb; 114(2):234-6. PubMed ID: 21239970
    [No Abstract]   [Full Text] [Related]  

  • 60. Recombinant human erythropoeitin: efficacy and safety considerations for maximizing blood conservation in cardiac surgery.
    Fox A
    Anesthesiology; 2011 Nov; 115(5):912-4. PubMed ID: 22027621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.